首页> Molecular and clinical oncology> Efficacy of weekly paclitaxel treatment as a single agent chemotherapy following first-line cisplatin treatment in urothelial bladder cancer.

Efficacy of weekly paclitaxel treatment as a single agent chemotherapy following first-line cisplatin treatment in urothelial bladder cancer.

导出 LinkOut

翻译打印收藏纠错

第一作者： Spyridon,Sideris

第一单位： Medical Oncology Clinic, Jules Bordet Institute, 1000 Brussels, Belgium.

作者： Spyridon,Sideris ^[1] ; Fouad,Aoun ^[2] ; Marc,Zanaty ^[3] ; Nieves Chanza,Martinez ^[4] ; Sofia,Latifyan ^[1] ; Ahmad,Awada ^[1] ; Thierry,Gil ^[1]

作者单位： Medical Oncology Clinic, Jules Bordet Institute, 1000 Brussels, Belgium. ^[1] Department of Urology, Jules Bordet Institute, 1000 Brussels, Belgium. ^[2] Data Center, Université Paris XII, 94010 Créteil, France. ^[3] Medical Oncology Clinic, University Hospital of Erasme, 1070 Brussels, Belgium. ^[4]

关键词 neutrophil to lymphocyte ratio overall survival paclitaxel toxicity urothelial cancer

DOI 10.3892/mco.2016.821

PMID 27284445

发布时间 2020-10-01

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Molecular and clinical oncology

2016年4卷6期

1063-1067页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

点击下载本期目录封面

Molecular and clinical oncology

2016年4卷6期

1063-1067页

检索历史清除

Efficacy of weekly paclitaxel treatment as a single agent chemotherapy following first-line cisplatin treatment in urothelial bladder cancer.

Molecular and clinical oncology

相似文献

Molecular and clinical oncology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Efficacy of weekly paclitaxel treatment as a single agent chemotherapy following first-line cisplatin treatment in urothelial bladder cancer.

Molecular and clinical oncology

相似文献

Molecular and clinical oncology

相关期刊

检索历史清除